Inhalation

Maureen Kadleck

Maureen is part of the Inhalation Technology Product Development Team at Lonza and has spent her four years with the company focusing on late-stage clinical projects, readying them for registration and process validation. She has taken projects through successful scale up and risk assessment processes across multiple platforms, including spray drying, encapsulation, twin-screw extrusion and fluid bed coating. Most recently, she has been focused on inhalation formulation development for small molecules and biologics.

Content by this expert

Recently published by Maureen

Respiratory Delivery of Gemcitabine for the Treatment of Lung Cancer

Respiratory Delivery of Gemcitabine for the Treatment of Lung Cancer